Xtant Medical Holdings Statistics
Total Valuation
XTNT has a market cap or net worth of $73.96 million. The enterprise value is $103.57 million.
Important Dates
The next estimated earnings date is Monday, November 11, 2024, before market open.
| Earnings Date | Nov 11, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
XTNT has 138.71 million shares outstanding. The number of shares has increased by 23.72% in one year.
| Shares Outstanding | 138.71M |
| Shares Change (YoY) | +23.72% |
| Shares Change (QoQ) | +0.05% |
| Owned by Insiders (%) | 7.28% |
| Owned by Institutions (%) | 6.92% |
| Float | 48.08M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.62 |
| Forward PS | 0.58 |
| PB Ratio | 1.54 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.93 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.44, with a Debt / Equity ratio of 0.78.
| Current Ratio | 2.44 |
| Quick Ratio | 0.94 |
| Debt / Equity | 0.78 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -4.00 |
Financial Efficiency
Return on equity (ROE) is -8.78% and return on invested capital (ROIC) is -12.64%.
| Return on Equity (ROE) | -8.78% |
| Return on Assets (ROA) | -10.58% |
| Return on Capital (ROIC) | -12.64% |
| Revenue Per Employee | $516,014 |
| Profits Per Employee | -$15,502 |
| Employee Count | 215 |
| Asset Turnover | 1.38 |
| Inventory Turnover | 1.40 |
Taxes
| Income Tax | -1.62M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -54.43% in the last 52 weeks. The beta is 0.38, so XTNT's price volatility has been lower than the market average.
| Beta (5Y) | 0.38 |
| 52-Week Price Change | -54.43% |
| 50-Day Moving Average | 0.61 |
| 200-Day Moving Average | 0.79 |
| Relative Strength Index (RSI) | 38.00 |
| Average Volume (20 Days) | 34,627 |
Short Selling Information
The latest short interest is 215,674, so 0.16% of the outstanding shares have been sold short.
| Short Interest | 215,674 |
| Short Previous Month | 192,425 |
| Short % of Shares Out | 0.16% |
| Short % of Float | 0.45% |
| Short Ratio (days to cover) | 3.83 |
Income Statement
In the last 12 months, XTNT had revenue of $110.94 million and -$3.33 million in losses. Loss per share was -$0.03.
| Revenue | 110.94M |
| Gross Profit | 68.36M |
| Operating Income | -13.61M |
| Pretax Income | -4.95M |
| Net Income | -3.33M |
| EBITDA | -9.70M |
| EBIT | -13.61M |
| Loss Per Share | -$0.03 |
Full Income StatementBalance Sheet
The company has $5.38 million in cash and $34.99 million in debt, giving a net cash position of -$29.61 million or -$0.21 per share.
| Cash & Cash Equivalents | 5.38M |
| Total Debt | 34.99M |
| Net Cash | -29.61M |
| Net Cash Per Share | -$0.21 |
| Equity (Book Value) | 45.01M |
| Book Value Per Share | 0.35 |
| Working Capital | 40.66M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$15.59 million and capital expenditures -$1.92 million, giving a free cash flow of -$17.52 million.
| Operating Cash Flow | -15.59M |
| Capital Expenditures | -1.92M |
| Free Cash Flow | -17.52M |
| FCF Per Share | -$0.13 |
Full Cash Flow StatementMargins
Gross margin is 61.61%, with operating and profit margins of -12.26% and -3.00%.
| Gross Margin | 61.61% |
| Operating Margin | -12.26% |
| Pretax Margin | -4.46% |
| Profit Margin | -3.00% |
| EBITDA Margin | -8.75% |
| EBIT Margin | -12.26% |
| FCF Margin | -15.51% |
Dividends & Yields
XTNT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -23.72% |
| Shareholder Yield | -23.72% |
| Earnings Yield | -4.51% |
| FCF Yield | -23.68% |
Analyst Forecast
The average price target for XTNT is $3.00, which is 462.64% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $3.00 |
| Price Target Difference | 462.64% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
The last stock split was on February 14, 2018. It was a reverse split with a ratio of 0.08333:1.
| Last Split Date | Feb 14, 2018 |
| Split Type | Reverse |
| Split Ratio | 0.08333:1 |
Scores
XTNT has an Altman Z-Score of -0.89 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.89 |
| Piotroski F-Score | 3 |